Who Is Moderna?
Moderna, Inc. is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases.
Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines.
To create a direct order account, visit: www.modernadirect.com
Where is Moderna Located?
Moderna is located in Cambridge, Massachusetts, USA.
What Year was Moderna Founded?
Moderna was founded in 2010.
Who is Moderna Owned By?
The top shareholders of Moderna are Robert S. Langer, Stéphane Bancel, Noubar B. Afeyan, Baillie Gifford & Company, and Flagship Pioneering Inc.
Who is on the Moderna Leadership Team?
Stéphane Bancel is the Chief Executive Officer of Moderna.
Moderna Vaccines History
Since 2010, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed.
Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing.
Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic.
Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases.
Today, 40 development programs are underway across these therapeutic areas, with over 13 programs having entered the clinic. Moderna has been named a top biopharmaceutical employer by Science for the past six years.
What is mRNA?
In 1960, a group of scientists identified a molecule that carries instructions inside a cell, like a blueprint to make proteins. They called it messenger RNA (mRNA).
The goal became to change that blueprint to help make new proteins and possibly help protect against disease by actually changing how we prevent and fight diseases.
But mRNA was hard to study because it was very fragile. So, the second effort was figuring out how to deliver this fragile molecule to be useful. mRNA needed an “envelope” for protection.
Almost three decades ago scientists began experimenting with surrounding mRNA with a fatty coat to protect it. This effort involved decoding what directions that the print should give the cell once it’s delivered. This happened over many years with many scientists studying many viruses and today the research efforts continue.
Today, Moderna continues to study mRNA to figure out if it’s possible to teach the human body to fight back against disease. Their research aims
to figure out ways to design mRNA that your cells can read to make proteins that your body needs but isn’t making for some reason.
You can think of this like antibodies for a virus that your body hasn’t seen yet. In other words, Moderna is studying mRNA to see if one day it could help teach our bodies to make its own medicine.
Is the Moderna COVID-19 Vaccine Available for Young Children?
The Moderna COVID-19 Vaccine, Bivalent is available for individuals 6 months of age and older.
Moderna Vaccines Ordering and Cost Savings With MPPG
Medical practices interested in saving money on Moderna’s COVID-19 vaccine, Spikevax™ may do so through their MPPG membership.
Moderna now has a direct purchase website. Creating a direct account with Moderna Direct will allow providers to reserve supply, ensure timely delivery, receive resources, and support, and manage your inventory with ease www.modernadirect.com
Moderna’s COVID vaccine will be available as well through authorized distributors.